Company Overview of Reven Pharmaceuticals, Inc.
Reven Pharmaceuticals, Inc., a development-stage healthcare company, focuses on development of products for the treatment of cardiovascular disease and related vascular disorders due to peripheral arterial disease (PAD), diabetes, and other circulatory disorders. Its product in pipeline includes Rejuveinix for the treatment of coronary artery diseases, PAD, endothelial dysfunction, and critical limb ischemia. The company was formerly known as Noventis, Inc. Reven Pharmaceuticals, Inc. was founded in 1999 and is based in Sarasota, Florida.
4411 Bee Ridge Road
Sarasota, FL 34233
Founded in 1999
Key Executives for Reven Pharmaceuticals, Inc.
Similar Private Companies By Industry
|PrinJohnson BioPharm, Inc.||United States|
|Keltman Pharmaceuticals, Inc.||United States|
|Biofilm, Inc.||United States|
|Mastix Medica LLC||United States|
|Teva Branded Pharmaceutical Products R&D, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Reven Pharmaceuticals, Inc., please visit revenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.